Manning Paul B (CIK 0001494695)

Latest company ownership

Shares held
657,985
Last filed at
Jul 8, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
625,657
Last filed at
Nov 25, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2018Q2 2025Q4
LQDA - Liquidia Corp
Role: Director
Shares held
479,233
Last filed at
May 4, 2022
Confidence Score
43.5
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
14,240
Last filed at
Jun 27, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
11,944
Last filed at
Sep 30, 2020
Confidence Score
52.4
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 25, 2025 Nov 25, 2025 Verrica Pharmaceuticals Inc. Director Buy 100.0 +4,126,142 109.15% ✗ $17.5M
Aug 28, 2025 Sep 2, 2025 Liquidia Corp Director Sell 15.0 -670,837 -15.70% ✗ $19M
May 30, 2025 Jun 3, 2025 Taysha Gene Therapies, Inc. 10% Owner Buy 100.0 +750,000 35.86% ✗ $2.1M
Dec 16, 2024 Dec 18, 2024 Candel Therapeutics, Inc. Director Buy 100.0 +1,250,000 43.45% ✗ $7.5M
Sep 12, 2024 Sep 16, 2024 Liquidia Corp Director Buy 95.0 +337,078 9.28% ✗ $3M
Jun 27, 2024 Jul 1, 2024 Taysha Gene Therapies, Inc. 10% Owner Buy 95.0 +1,333,333 5.67% ✗ $3M
Dec 14, 2023 Dec 18, 2023 Liquidia Corp Director Buy 100.0 +279,330 25.09% ✗ $2M
Nov 17, 2023 Nov 20, 2023 Taysha Gene Therapies, Inc. 10% Owner Buy 72.5 +100,000 0.61% ✗ $163K
Aug 16, 2023 Aug 16, 2023 Taysha Gene Therapies, Inc. 10% Owner Buy 100.0 +16,466,667 100.00% ✗ $14.8M
Jul 24, 2023 Jul 24, 2023 Verrica Pharmaceuticals Inc. Director Buy 87.5 +200,000 1.30% ✗ $1M
Oct 31, 2022 Nov 2, 2022 Taysha Gene Therapies, Inc. Director Buy 100.0 +1,500,000 27.52% ✗ $3M
Jul 5, 2022 Jul 5, 2022 Verrica Pharmaceuticals Inc. Director Buy 100.0 +4,761,904 44.81% ✗ $10M
Apr 18, 2022 Apr 19, 2022 Liquidia Corp Director Buy 100.0 +392,156 57.87% ✗ $2M
Feb 2, 2022 Feb 4, 2022 Taysha Gene Therapies, Inc. Director Buy 92.5 +201,602 4.89% ✗ $1.6M
Dec 2, 2021 Dec 6, 2021 Verrica Pharmaceuticals Inc. Director Buy 67.5 +50,000 0.47% ✗ $467.9K
Nov 24, 2021 Nov 29, 2021 Taysha Gene Therapies, Inc. Director Buy 48.8 +2,202 0.04% ✗ $29K
Nov 23, 2021 Nov 24, 2021 Taysha Gene Therapies, Inc. Director Buy 67.5 +20,000 0.38% ✗ $250.8K
Jul 29, 2021 Aug 4, 2021 Candel Therapeutics, Inc. Director Buy 100.0 +1,625,000 2901.79% ✗ $13M
Jul 27, 2021 Jul 29, 2021 Candel Therapeutics, Inc. Director Buy 97.5 +56,000 100.00% ✗ $410.8K
Jul 6, 2021 Jul 8, 2021 Acumen Pharmaceuticals, Inc. 10% Owner Buy 100.0 +312,500 10.28% ✗ $5M
May 14, 2021 May 17, 2021 Taysha Gene Therapies, Inc. Director Buy 67.5 +12,000 0.23% ✗ $251.8K
Apr 13, 2021 Apr 15, 2021 Liquidia Corp Director Buy 97.5 +198,413 36.80% ✗ $500K
Mar 25, 2021 Mar 29, 2021 Verrica Pharmaceuticals Inc. Director Buy 97.5 +739,830 9.13% ✗ $10.9M
Aug 20, 2020 Aug 21, 2020 Verrica Pharmaceuticals Inc. Director Buy 65.0 +20,000 0.20% ✗ $181.8K
Aug 18, 2020 Aug 19, 2020 Verrica Pharmaceuticals Inc. Director Buy 60.0 +10,000 0.10% ✗ $85.5K
Aug 17, 2020 Aug 18, 2020 Verrica Pharmaceuticals Inc. Director Buy 56.3 +6,000 0.06% ✗ $41.5K
Aug 13, 2020 Aug 17, 2020 Verrica Pharmaceuticals Inc. Director Buy 87.5 +158,500 1.69% ✗ $1M
Oct 8, 2019 Oct 10, 2019 Verrica Pharmaceuticals Inc. Director Buy 67.5 +20,886 0.22% ✗ $300.3K
Jan 7, 2019 Jan 7, 2019 Verrica Pharmaceuticals Inc. Director Buy 75.0 +47,500 0.51% ✗ $530.8K
Nov 12, 2018 Nov 14, 2018 Verrica Pharmaceuticals Inc. Director Buy 75.0 +70,200 0.76% ✗ $993K
Jun 19, 2018 Aug 15, 2018 Verrica Pharmaceuticals Inc. Director Buy 92.5 +300,000 3.35% ✗ $4.5M
Aug 10, 2018 Aug 14, 2018 Verrica Pharmaceuticals Inc. Director Buy 67.5 +33,000 0.36% ✗ $497.6K